POLY MEDICURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2023 inter alia to consider and approve a) the Audited Financial Results (Consolidated & Standalone) of the Company for the financial year ended on 31st March 2023.b) recommendation of Final Dividend if any on the Equity Shares for the financial year ended on 31st March 2023.c) any other matter which the Board may deem fit.In continuation of our intimation regarding closure of trading window vide letter dated 31st March 2023 the Trading Window for dealing in securities of the Company shall remain closed till 11th May 2023.This is for your information and record.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
